Akari Therapeutics, Plc (AKTX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0.25
Day's range
$0.25

Akari Therapeutics Plc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
MMCAP INTERNATIONAL INC. SPC 08/14/2026 100.00 K $1.02 M   100.00% 5.58%
CRESSET ASSET MANAGEMENT, LLC 08/14/2026 20.56 K $210.65 K   0.00% 1.15%
JANE STREET GROUP, LLC 08/14/2026 15.46 K $158.42 K   100.00% 0.86%
HRT FINANCIAL LP 08/14/2026 13.75 K $140.00 K   100.00% 0.77%
CITADEL ADVISORS LLC 09/02/2026 10.00 K $102.45 K   100.00% 0.56%
IFP ADVISORS, INC 07/20/2026 181 $1.85 K   0.00% 0.01%
SBI SECURITIES CO., LTD. 07/23/2026 14 $143   180.00% 0.00%
CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD 08/05/2026 8 $82   100.00% 0.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 08/12/2026 7 $72   100.00% 0.00%
TRUVESTMENTS CAPITAL LLC 08/12/2026 1 $10   0.00% 0.00%
MORGAN STANLEY 08/13/2026 0 $0   -100.00% 0.00%
ARMISTICE CAPITAL, LLC 08/14/2026 0 $0   -100.00% 0.00%
IFP ADVISORS, INC 07/20/2026 0 $0   -100.00% 0.00%

Akari Therapeutics Plc institutional Ownership - FAQ's

During the previous two years, 14 institutional investors and hedge funds held shares of Akari Therapeutics Plc. The most heavily invested institutionals were:

MMCAP International Inc. SPC: 100,000

Cresset Asset Management, LLC: 20,561

JANE STREET GROUP, LLC: 15,463

HRT FINANCIAL LP: 13,745

IFP Advisors, Inc: 181

SBI Securities Co., Ltd.: 14

8.37% of Akari Therapeutics Plc stock is owned by institutional investors.

Institutional investors have bought a total of 321.83 K shares in the last 24 months. This purchase volume represents approximately $80.46 K in transactions.